Cargando…
Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of borte...
Autores principales: | Kharel, Prakash, Uprety, Deekchha, Chandra, Abhinav B., Hu, Yirui, Belur, Anuradha Avinash, Dhakal, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286773/ https://www.ncbi.nlm.nih.gov/pubmed/30595697 http://dx.doi.org/10.1155/2018/2913124 |
Ejemplares similares
-
Neratinib-Induced Duodenal Ulcer: A Case Report
por: Moftakhar, Bahar, et al.
Publicado: (2020) -
Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021) -
Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
por: Charaf, Edriss, et al.
Publicado: (2009) -
Systemic Melioidosis with Acute Osteomyelitis and Septic Arthritis Misdiagnosed as Tuberculosis: A Case Report
por: Prasad, Rohit, et al.
Publicado: (2020) -
A Case Report on Bortezomib-Induced Bilateral Chalazion
por: Paravathaneni, Mahati, et al.
Publicado: (2020)